Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

Aim: Recent studies have demonstrated that selective sodium–glucose cotransporter 2 inhibitors (SGLT2is) reduce cardiovascular events, although their mechanism remains obscure. We examined the effect of canagliflozin, an SGLT2i, on atherogenesis and investigated its underlying mechanism. Method: Can...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahadian, Arief, Fukuda, Daiju, Salim, Hotimah Masdan, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Sata, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803832/
https://www.ncbi.nlm.nih.gov/pubmed/32101837
http://dx.doi.org/10.5551/jat.52100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803832/
https://www.ncbi.nlm.nih.gov/pubmed/32101837
http://dx.doi.org/10.5551/jat.52100

Ejemplares similares